Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Wockhardt , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Wockhardt Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price271.1
Previous Share Price276.0
Price Change -4.90
Change % -1.78%
Volume347.97 K
Five Day Avg Vol425.17 K
Last Business Date07-Jul-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week -9.80 -3.49
Two Weeks -22.30 -7.60
One Month 14.55 5.67
Three Months 68.50 33.81
Six Months 30.10 12.49
One Year -91.40 -25.21
Compare WOCKPHARMA with Peers/ Index

Highs / Lows

One Week283.7268.0
Two Weeks298.1268.0
One Month309.45232.0
Three Months309.45203.0
Six Months411.65146.7
One Year411.65146.7

Key Moving Average

5 Days 275.53275.518
15 Days 278.853274.1
20 Days 272.76271.09
50 Days 253.615260.112
100 Days 259.687260.518
200 Days 266.569280.754
Detailed MA Analysis of WOCKPHARMA ...

Key Technical Indicators

MACD 7.97
RSI 51.85
RSI (Smooth) 52.78
ADX 20.87
Chaikin Money Flow -0.066
Williams %R -81.77
PSAR 309.45
Detailed Tech Analysis WOCKPHARMA ...

Financial Data Highlights

Market Cap3147.63
Book Value/ Share229.135
Enterprise Value323.90
Revenue TTM3513.57
Gross Profit TTM2262.09
Revenue /Share TTM317.30
Consensus Target450.00
Key Financial Highlights WOCKPHARMA ...

Financial Ratios of WOCKPHARMA

Div Yield0
Trailing PE0
Forward PE0
Key Financial Ratios of WOCKPHARMA ...

Key Profit & Loss Data

Net Inc -194.53 68.02 %
Ops Income-31.09 84.83 %
Revenue4139.94 5.16 %
Ops Expense4171.03 0.704 %
PBT-300.32 53.16 %
Gross Profit2277.75 8.86 %
Div Paid-0.0200 80.00 %

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR9.203.39
Week PR14.005.16
Month PR15.705.79
5 Day Period7.812.87
10 Day Period10.313.73
5 Week Period26.029.94
3 Months Period53.2024.20
Price Range /Volatility WOCKPHARMA ...

Highlights & Chart Patterns of Wockhardt Ltd.

Stock has jumped by more than 15% in last One Month from its lowest level of 232.0 dt 12-Jun-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 203.0 dt 08-Apr-20.
Stock has jumped by more than 50% in last Six Month from its lowest level of 146.7 dt 24-Mar-20.
Share has hit Two Week high on 07-Jul-20.
Stock has fallen by more than 50% in last three Month from its highest level of 411.65 dt 11-Feb-20.
Share is making strong moves on recent Monthly chart. Such movements may give an opportunity for short term trading.
Bullish harami Candlestick pattern was formed by Wockhardt Ltd. on 03/07/2020
More Chart Patterns Wockhardt Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Wockhardt Ltd.

Date Open High Low Close Volume
07-Jul-20 277.00 277.20 268.00 271.10 347 K
06-Jul-20 278.25 282.00 274.30 276.00 465 K
03-Jul-20 275.25 277.85 272.75 275.75 292 K
02-Jul-20 282.00 282.45 273.20 274.75 536 K
01-Jul-20 280.90 283.70 272.00 280.05 483 K
30-Jun-20 293.20 294.25 278.50 280.90 747 K
29-Jun-20 287.00 296.40 286.50 291.70 1034 K
26-Jun-20 283.90 293.70 281.50 285.45 883 K
25-Jun-20 280.00 287.50 275.50 282.45 594 K
24-Jun-20 297.00 298.10 280.25 282.60 835 K
About Wockhardt Limited
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients (APIs), formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, a r-DNA insulin; Wepox, a recombinant erythropoietin is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 2349, WCK 4873, and WCK 4086 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.